Skip to content

DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer

DESCANSO/REST (Depresión/Depressed Mood, Cansancio/Fatigue, and Sueño/Sleep): A Trial Assessing Feasibility and Acceptability of an Intervention for Depressed Mood, Insomnia, and Fatigue Symptoms in Latino Cancer Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07225088
Enrollment
125
Registered
2025-11-05
Start date
2026-01-23
Completion date
2030-07-31
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Tumor, Solid Tumor, Adult

Keywords

Solid Tumor, Solid Tumor Stage I, Solid Tumor Stage II, Solid Tumor Stage III, Memorial Sloan Kettering Cancer Center, 25-277

Brief summary

The purpose of this study is to improve ways of providing mental health support to Spanish-speaking Latino participants who have cancer and experience depression, insomnia, and fatigue. Investigators will test a special mental health intervention called DESCANSO/REST (Depresión/Depressed Mood, Cansancio/Fatigue, and Sueño/Sleep). The intervention can be delivered through telehealth.

Interventions

BEHAVIORALDESCANSO/Depresión/Depressed Mood, Cansancio/Fatigue, and Sueño/Sleep; Rest in English

DESCANSO (Depresión/Depressed Mood, Cansancio/Fatigue, and Sueño/Sleep; Rest in English)

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

Provider Eligibility Criteria: Participant eligibility will be determined by a self-report screener. Inclusion Criteria Self-Report Criteria * Mental health provider * Treats Latino cancer patients and/or survivors * Has at least 3 years of clinical experience providing psychosocial services to cancer patients and/or survivors * Able to read Spanish determined by the question: "Can you read in Spanish? Yes/No" Patient Eligibility Criteria: A patient cannot be considered eligible for this study unless ALL of the following conditions are met. Participant eligibility will be determined by an initial EMR review followed by a self-report screener. Inclusion Criteria EMR Criteria * Documentation of Disease o Pathologically confirmed solid tumor cancer (either most recent or new diagnosis) * Definition of Disease \[or Measurable Disease\] o Diagnosed with stages I, II, or III * Prior Treatment * Currently undergoing systemic therapy (chemotherapy, radiation therapy, and/or immunotherapy) or within the first year following completion of systemic therapy Self-Report Criteria * Age ≥ 21 years * Lives in mainland U.S. or Puerto Rico * Identifies as Latino/a or Hispanic * Reports Spanish as their preferred language * Speaks Spanish "Very well" or "Well" as determined by the question: "How well do you speak Spanish?" * Presence of fatigue and disturbed sleep determined by a score of ≥ 3 on the MD Anderson Symptom Inventory

Exclusion criteria

EMR Criteria o In the judgment of the treating physician, protocol investigators, and/or study staff, presence of cognitive impairment (e.g., delirium or dementia) sufficient to preclude meaningful informed consent and/or study participation Self-Report Criteria * History of comorbidities within the last 12 months associated with fatigue and poor sleep, including hypothyroidism or abnormal thyroid function, sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, alcohol or drug abuse * Pregnant or lactating, women only * Presence of suicidal risk determined by any affirmative response on the Columbia-Suicide Severity Rating Scale

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who complete at least 5 DESCANSO sessionsUp to 1 yearFeasibility of DESCANSO (Depresión/Depressed Mood, Cansancio/Fatigue, and Sueño/Sleep) defined as completing at least 5 out of the planned 8 DESCANSO sessions.

Countries

United States

Contacts

CONTACTDevika Jutagir, PhD
jutagird@mskcc.org646-888-8361
CONTACTVictoria Blinder, MD
blinderv@mskcc.org646-888-4808
PRINCIPAL_INVESTIGATORDevika Jutagir, PhD

Memorial Sloan Kettering Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026